Niño de 3 meses con anemia hemolítica no autoinmune. Article in Anales de Pediatría 55(3)– · December with 6 Reads. Article in Anales de Pediatría 71(3) · September with 56 Reads Anemia hemolítica autoinmune con prueba de antiglobulina positiva a. de Medicina Interna de una institución pediátrica de alto nivel de complejidad. El paciente consultó por un cuadro de anemia hemolítica autoinmune.

Author: Gardara Tygotaur
Country: Saint Kitts and Nevis
Language: English (Spanish)
Genre: Medical
Published (Last): 5 February 2005
Pages: 465
PDF File Size: 9.79 Mb
ePub File Size: 14.62 Mb
ISBN: 177-9-38531-700-6
Downloads: 85772
Price: Free* [*Free Regsitration Required]
Uploader: Visida

Rituximab for the treatment of juvenile dermatomyositis: The role and efficacy of antibiotic prophylaxis in this setting remains unclear, and not pediatriz investigators recommend this approach.

Incidence and risk factors of relapses in idiopathic autoimmune hemolytic anemia. Moreover, concomitant therapy with steroids and immunosuppressive drugs often made it difficult to define the contribution of this procedure to the outcome.

Rituximab in pediatric population: The case of vasculitis was found response to therapy and the patient with juvenile dermatomyositis was refractory. Plasma exchange has been performed in a relatively small number of severely affected warm AIHA patients, both children and adults, in whom the anemia could not be stabilized with steroids and transfusion therapy alone, as a temporizing measure.

Hemolysis is the destruction or removal of red blood cells from the circulation before their normal. Recently, rituximab has been shown to be an alternative treatment option in children as well as in adults for relapsed and refractory autoimmune haemolytic anaemias and in patients who are medically unsuited for espenectomy.

Comparative response to splenectomy in Coombs-positive auto-immune hemolytic anemia with or without associated disease. However, their use is controversial, primarily because only small case series have been reported. Blood Banking and Transfusion Medicine. The direct Coombs polyspecific test was positive in 13 and negative in four patients.


Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.

Efficacy and safety of low-dose alemtuzumab as treatment of autoimmune hemolytic anemia in pretreated B-cell chronic lymphocytic leukemia. How I manage cold agglutinin disease. Cases J, 2pp. However, no controlled clinical trials have yet been performed that can guide the choice of auroinmune.

Hemolytic anemias due to erythrocyte enzyme deficiencies. Laparoscopic splenectomy for hematologic diseases: J Pediatr Hematol Oncol. Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia. Patients with AIHA may often require red blood cell RBC transfusion to maintain clinically acceptable hemoglobin values, at least pediarria specific treatments become effective. Clin Lymphoma Myeloma Leuk. Int Immunopharmacol, 9pp. Revista Brasileira de Oftalmologia.

You can change the settings or obtain more information by clicking here. Rituximab, a monoclonal antibody directed against the CD20 antigen expressed on B cells, has been shown to be effective in AIHA, although the comparison of response rates in various studies is difficult in the absence of common response criteria.

Additional therapies are intravenous immunoglobulins, danazol, wnemia, and alemtuzumab and high-dose cyclophosphamide as last resort option.

Hemoglobin Perth in Costa Rica. Prognosis is worse in patients with chronic underlying diseases. AIHA may develop gradually, or have a fulminant onset with life-threatening anemia. Universidad de los Andes. Rheumatology Oxford44pp. General Info About me I specialized in pediatrics because children are honest and their smile is the best gift you can get. Thrombotic Thrombocytopenic Purpura associated with Clopidogrel: Thrombotic microangiopathy in Systemic Lupus Erythematosus: Efficacy of danazol in hematologic disorders.

Pediatrics Country of publisher: Serological characteristics and transfusion efficacy evaluation in 61 cases of autoimmune hemolytic anemia. A hepatic cirrhosis and hemolytic anemia is reported due to wd, in an female adolescent of age, with family antecedent of a sister with wd.


B-cell depletion and repopulation in autoimmune diseases.

There was a problem providing the content you requested

Warm autoimmune hemolytic anemia: Safety and efficacy of rituximab in severe juvenile dermatomyositis: Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.

Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab humanized CD52 monoclonal antibody. Autoimmune hemolytic anemia with reticulocytopenia.

Consolidation treatment with rituximab induces complete and persistent remission of mixed type Evans syndrome. Delayed hemolysis after treatment hemoltica parenteral artesunate in african children with severe malaria a doublecenter prospective study.

Kathia Valverde Muñoz – Pediatrics, Pediatric Hematology – Metropolitano Hospital

Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia. S9—S56 [ PubMed ]. In the past, PCH was mainly associated with syphilis, and now usually follows viral and bacterial infections, including Mycoplasma pneumonia.

Clinical syndromes at higher risk for malignacy. High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. Splenectomy is commonly pedaitria to be the most effective conventional second-line treatment of warm AIHA to be proposed to patients unresponsive or intolerant to corticosteroids, in those that require a daily maintenance dose of prednisone greater than 10 mg, and in those with multiple relapses.

Rituximab therapy for autoimmune haematological diseases.